These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37264095)

  • 1. Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome.
    Liu M; Li G; Song X; Fan Y; Li C
    Sci Rep; 2023 Jun; 13(1):8915. PubMed ID: 37264095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke and Risk Factors in Antiphospholipid Syndrome.
    Fan Y; Xu Y; Zhang S; Song X; Liu Z; Tu W; Li C
    J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Serbian Primary Antiphospholipid Syndrome Patients Confirmed a Strong Association Between Livedo Reticularis and Arterial Thrombosis: A National Cross-Sectional Cohort Study.
    Djokovic A; Stojanovich L; Stanisavljevic N; Matic P; Colic D; Skrijelj D; Djokic S; Filipovic B
    J Clin Rheumatol; 2022 Oct; 28(7):362-366. PubMed ID: 35697016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for arterial thrombosis in antiphospholipid syndrome.
    Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J
    Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Antiphospholipid Syndrome with Livedo Reticularis is Linked to Female Sex and Stroke and Negatively Associated with Thyroid Disease.
    Carvalho JF; de Araujo RPC; Skare TL
    Curr Rheumatol Rev; 2022; 18(4):352-356. PubMed ID: 34784875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome.
    Toubi E; Krause I; Fraser A; Lev S; Stojanovich L; Rovensky J; Blank M; Shoenfeld Y
    Clin Exp Rheumatol; 2005; 23(4):499-504. PubMed ID: 16095119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features associated with epilepsy in the antiphospholipid syndrome.
    Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J
    J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.
    Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA;
    Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study.
    Guédon AF; Catano J; Ricard L; Laurent C; de Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Maillot F; Boffa JJ; Cohen A; Abisror N; Fain O; Mekinian A
    Arthritis Res Ther; 2022 Jan; 24(1):33. PubMed ID: 35078523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
    Cervera R; Piette JC; Font J; Khamashta MA; Shoenfeld Y; Camps MT; Jacobsen S; Lakos G; Tincani A; Kontopoulou-Griva I; Galeazzi M; Meroni PL; Derksen RH; de Groot PG; Gromnica-Ihle E; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Roch B; Fernández-Nebro A; Boffa MC; Hughes GR; Ingelmo M;
    Arthritis Rheum; 2002 Apr; 46(4):1019-27. PubMed ID: 11953980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.
    Stojanovich L; Djokovic A; Stanisavljevic N; Zdravkovic M
    Lupus; 2018 Apr; 27(5):858-863. PubMed ID: 29301476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.
    Cervera R; Boffa MC; Khamashta MA; Hughes GR
    Lupus; 2009 Sep; 18(10):889-93. PubMed ID: 19671788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune hemolytic anaemia in the antiphospholipid syndrome.
    Rottem M; Krause I; Fraser A; Stojanovich L; Rovensky J; Shoenfeld Y
    Lupus; 2006; 15(7):473-7. PubMed ID: 16898185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome.
    Pérez D; Stojanovich L; Naranjo L; Stanisavljevic N; Bogdanovic G; Serrano M; Serrano A
    Front Immunol; 2018; 9():2644. PubMed ID: 30524428
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
    Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome-mediated acute cerebrovascular diseases and long-term outcomes.
    García-Grimshaw M; Posadas-Pinto DR; Jiménez-Ruiz A; Valdés-Ferrer SI; Cadena-Fernández A; Torres-Ruiz JJ; Barrientos-Guerra JD; Amancha-Gabela M; Chiquete E; Flores-Silva FD; Cantú-Brito C
    Lupus; 2022 Feb; 31(2):228-237. PubMed ID: 35042376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibody positive Sneddon syndrome: a case report.
    Tosunoğlu B; Basut FS; Başer B; Altikardeş M; Inan LE
    Folia Med (Plovdiv); 2024 Feb; 66(1):132-135. PubMed ID: 38426476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.
    Uludağ Ö; Bektaş M; Çene E; Sezer M; Şahinkaya Y; Gül A; Inanç M; Öcal L; Artim-Esen B
    J Thromb Thrombolysis; 2021 Feb; 51(2):466-474. PubMed ID: 32588289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases.
    Francès C; Niang S; Laffitte E; Pelletier Fl; Costedoat N; Piette JC
    Arthritis Rheum; 2005 Jun; 52(6):1785-93. PubMed ID: 15934071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome and recurrent thrombosis in children.
    Berkun Y; Padeh S; Barash J; Uziel Y; Harel L; Mukamel M; Revel-Vilk S; Kenet G
    Arthritis Rheum; 2006 Dec; 55(6):850-5. PubMed ID: 17139660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.